501085-54-7

Basic information

• Product Name: Phenol, 4-bromo-2-(dimethoxymethyl)-
• CAS NO: 501085-54-7
• Molecular Formula: C9H11BrO3
• Molecular Weight: 247.089
• Mol File: 501085-54-7.mol
• Article Data: 7

Chemical Properties

• CAS DataBase Reference: Phenol, 4-bromo-2-(dimethoxymethyl)-(CAS DataBase Reference)
• NIST Chemistry Reference: Phenol, 4-bromo-2-(dimethoxymethyl)-(501085-54-7)
• EPA Substance Registry System: Phenol, 4-bromo-2-(dimethoxymethyl)-(501085-54-7)

Safety Data

• Hazardous Substances Data: 501085-54-7(Hazardous Substances Data)

Upstream product

• 1761-61-1 5-bromosalicyclaldehyde 
• 67-56-1 methanol 
• 149-73-5 trimethyl orthoformate 

Downstream Products

• 944162-02-1 2-(2-(4-bromo-2-(dimethoxymethyl)phenoxy)ethyl)thiophene 
• 343306-50-3 4-(3-formyl-4-hydroxyphenyl)piperazine-1-carboxylic acid tert-butyl ester 
• 182344-24-7 3-formyl-4-hydroxyphenylboronic acid 
• 944162-11-2 t-butyl 2-(4-bromo-2-(dimethoxymethyl)phenoxy)ethylmethylcarbamate 
• 1761-61-1 5-bromosalicyclaldehyde 

Relevant articles and documents

Method for preparing vilazodone intermediate through copper-catalyzed coupling reaction

The invention discloses a method for preparing a vilazodone intermediate through a copper-catalyzed coupling reaction. The method comprises the following steps: step 1, generating 2-hydroxy-5-bromobenzene dimethyl acetal (IV) from 2-hydroxy-5-bromobenzald

Long-range diastereoselectivity in an Ugi reaction: Stereocontrolled and diversity-oriented synthesis of tetrahydrobenzoxazepines

Salicylaldehydes and protected 1,2-amino alcohols have been convergently converted into a series of 2,3-dihydrobenzo[f][1,4]oxazepines, which undergo an Ugi-Joullie multicomponent reaction with unusual long-range diastereoselectivity. This protocol allows

RHODANDSE DERIVARIVES, A PROCESS FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME

Disclosed herein are rhodanine derivatives, a method for the preparation thereof, and a pharmaceutical composition containing the same. The rhodanine derivatives have inhibitory activity against protein phosphatases (PPase) such as PTPlB, Prl-3, LAR, CD45